ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
澳股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
NEUROTECH INTERNATIONAL LTD
0.013
0.000
成交量:
55.90萬
成交額:
7,267
市值:
2,100.89萬
市盈率:
-2.35
高:
0.014
開:
0.013
低:
0.013
收:
0.013
52周最高:
0.029
52周最低:
0.010
股本:
16.16億
流通股本:
7.68億
量比:
0.33
換手率:
0.07%
股息:
- -
股息率:
- -
每股收益(TTM):
-0.006
每股收益(LYR):
-0.006
淨資產收益率:
-366.75%
總資產收益率:
-138.02%
市淨率:
34.38
市盈率(LYR):
-2.35
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
Neurotech International 獲約450萬澳元定向增資承諾,發行價每股0.014澳元
投资观察
·
08/04
Neurotech International 完成約450萬澳元股份配售,每股定價0.014澳元
美股速递
·
08/04
Neurotech International宣佈美國FDA已批准NTI164的IND申請
投资观察
·
07/14
分析-2025年,隨着高價基因療法上市數量減少,美國新藥價格出現下降
路透中文
·
06/25
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/NTI.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NTI.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NTI.AU\",,,,,undefined,":{"symbol":"NTI.AU","market":"AU","secType":"STK","nameCN":"NEUROTECH INTERNATIONAL LTD","latestPrice":0.013,"timestamp":1789452720000,"preClose":0.013,"halted":0,"volume":558997,"delay":0,"changeRate":0,"nameEN":"NEUROTECH INTERNATIONAL LTD","floatShares":768083617,"shares":1616069964,"eps":-0.005531,"marketStatus":"未開盤","change":0,"latestTime":"09-15 16:12:00 AEST","open":0.013,"high":0.014,"low":0.013,"amount":7267,"amplitude":0.076923,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.005531,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1789516800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.013,"openAndCloseTimeList":[[1789430400000,1789452000000]],"volumeRatio":0.3336065460520543,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"NTI.AU","preClose":0.013,"auctionPrice":0.014,"auctionVolume":71,"auctionTime":1789506209318,"referenceTime":1789468203091,"auction":1,"marketStatus":"盘前竞价","timestamp":1789506209318}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NTI.AU\",,,,,undefined,":{"symbol":"NTI.AU","floatShares":768083617,"roa":"-138.02%","roe":"-366.75%","lyrEps":-0.005531,"volumeRatio":0.3336065460520543,"shares":1616069964,"dividePrice":0,"high":0.014,"amplitude":0.076923,"preClose":0.013,"low":0.013,"week52Low":0.01,"pbRate":"34.38","psRate":"4.44","week52High":0.029,"institutionHeld":0,"latestPrice":0.013,"eps":-0.005531,"divideRate":0,"volume":558997,"delay":0,"ttmEps":-0.005531,"open":0.013,"prevYearClose":0.014,"prevWeekClose":0.013,"prevMonthClose":0.014,"prevQuarterClose":0.014,"fiveDayClose":0.013,"twentyDayClose":0.014,"sixtyDayClose":0.013,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NTI.AU\",params:#limit:5,,,undefined,":[{"date":"2023-10-27","symbol":"NTI.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1698361200000,"name":null,"time":"","dateTimestamp":1698325200000,"actualEps":null},{"date":"2023-07-26","symbol":"NTI.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1690329600000,"name":null,"time":"","dateTimestamp":1690293600000,"actualEps":null},{"market":"AU","date":"2023-04-27","symbol":"NTI.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1682517600000,"reportTimeType":"","actualEps":null},{"date":"2023-01-30","symbol":"NTI.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1675033200000,"name":null,"time":"","dateTimestamp":1674997200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NTI.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NTI.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1168763117","title":"Neurotech International 獲約450萬澳元定向增資承諾,發行價每股0.014澳元","url":"https://stock-news.laohu8.com/highlight/detail?id=1168763117","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168763117?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 09:55","pubTimestamp":1785808538,"startTime":"0","endTime":"0","summary":"Neurotech International Ltd(代码:NTI.AX)宣布,已获得总额约450万澳元的定向增资承诺。此次配售的价格设定为每股0.014澳元。这一消息于8月4日对外公布,标志着公司资本运作迈出关键一步。相关细节已在随后的公司公告中进一步披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTI.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120903726","title":"Neurotech International 完成約450萬澳元股份配售,每股定價0.014澳元","url":"https://stock-news.laohu8.com/highlight/detail?id=1120903726","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120903726?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 07:29","pubTimestamp":1785799763,"startTime":"0","endTime":"0","summary":"Neurotech International 已获得具有约束力的认购承诺,将通过股份配售募集约450万澳元。此次配售的定价为每股0.014澳元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","NTI.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101553097","title":"Neurotech International宣佈美國FDA已批准NTI164的IND申請","url":"https://stock-news.laohu8.com/highlight/detail?id=1101553097","media":"投资观察","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101553097?lang=zh_tw&edition=fundamental","pubTime":"2026-07-14 09:56","pubTimestamp":1783994192,"startTime":"0","endTime":"0","summary":"Neurotech International Ltd 宣布,其新药NTI164的试验性新药申请已获得美国食品药品监督管理局的批准。\n这一监管进展为该公司推进其候选药物的临床开发计划铺平了道路。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTI.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646794508","title":"分析-2025年,隨着高價基因療法上市數量減少,美國新藥價格出現下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2646794508","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646794508?lang=zh_tw&edition=fundamental","pubTime":"2026-06-25 18:01","pubTimestamp":1782381707,"startTime":"0","endTime":"0","summary":"分析-2025年,随着高价基因疗法上市数量减少,美国新药价格出现下降2025年获FDA批准的药品年均标价中位数为216,000美元2025年,FDA批准了51种新药,其中包括5种细胞和基因疗法2025年获批药物中,小分子药物占比超过67%,高于2024年的62%Deena Beasley路透6月25日-一项最新分析显示,2025年美国监管机构批准的处方药上市价格虽较上年有所下降,但受罕见病高价药物影响,中位数仍高达216,000美元。基因疗法通常只需给药一次,其价格可能高达数百万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nL4S42X0VU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4548","JAZZ","LU0109394709.USD","LU0154245673.USD","LU0154245756.USD","LENZ","IE00BN0W2T93.GBP","BK7501","BK4588","LU0114720955.EUR","IE00BN0W2W23.USD","LU0889565916.HKD","CSL.AU","LU0320765992.SGD","ALNY","IE00BN0W2V16.EUR","BK4585","BK7511","BK4539","LU0882574055.USD","BK7508","BK7007","NTI.AU","BK4533","BK4532","BK7067","IONS","LU0823416689.USD","ABEO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NTI.AU\",params:#limit:6,delay:true,,,undefined,":[]}}